title: A paucity of unusual trihydroxy bile acids in the urine of patients with severe liver diseases.
abstract: To clarify the relationship between the occurrence of unusual trihydroxy bile acids, namely hyocholic acid, ursocholic acid (UCA), and omega-muricholic acid (omega-MCA) in urine and liver disease severity, urinary bile acids were analyzed by gas-liquid chromatography in acute and late phases of acute hepatitis and before and after ursodeoxycholic acid (UDCA) loading in healthy adults and liver cirrhosis patients. In 11 patients with acute hepatitis, the occurrence rates and amounts of unusual trihydroxy bile acids were increased in the late (recovery) phase, as compared with those in the early phase. In 10 patients with severe acute hepatitis who had prothrombin times exceeding 16 seconds, these bile acids had completely disappeared from the urine in the early phase but reappeared in the late phase in those who had a good outcome, though never in a patient who died. After UDCA administration for a week, the amounts of unusual bile acids, especially UCA and omega-MCA, which are thought to be synthesized through 12 alpha- and 6 alpha-hydroxylations, respectively, from UDCA, were clearly increased in 10 healthy adults but only slightly changed in 10 patients with liver cirrhosis. In conclusion, hepatic hydroxylations of dihydroxy bile acids as a detoxification reaction were impaired in severe liver diseases, which may play a role in the intensification and perpetuation of hepatocellular injuries.
authors.affiliation: Third Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.nakashim@koto.kpu-m.ac.jp
authors.forename: T
authors.initials: T
authors.lastname: Nakashima
authors.forename: Y
authors.initials: Y
authors.lastname: Sakamoto
authors.forename: K
authors.initials: K
authors.lastname: Inaba
authors.forename: H
authors.initials: H
authors.lastname: Mitsuyoshi
authors.forename: H
authors.initials: H
authors.lastname: Ishikawa
authors.forename: Y
authors.initials: Y
authors.lastname: Nakajima
authors.forename: M
authors.initials: M
authors.lastname: Sakai
authors.forename: T
authors.initials: T
authors.lastname: Shima
authors.forename: K
authors.initials: K
authors.lastname: Kashima
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002756:Cholagogues and Choleretics / Q000494:pharmacology; D002793:Cholic Acids / Q000737:chemistry / Q000652:urine*; D005260:Female; D006505:Hepatitis / Q000652:urine*; D006801:Humans; D008103:Liver Cirrhosis / Q000652:urine*; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D012720:Severity of Illness Index; D014580:Ursodeoxycholic Acid / Q000494:pharmacology
chemical_list: D002756:Cholagogues and Choleretics; D002793:Cholic Acids; C004821:muricholic acid; D014580:Ursodeoxycholic Acid; C030712:ursocholic acid